Induction cycles | Anthracyclines | Total CR/n (%) | R882 wild-type CR/n (%) | R882 mutation CR/n (%) | OR (95% CI) | P value |
---|---|---|---|---|---|---|
First cycle | Aclarubicin | 95/187 (50.80) | 92/173 (53.18) | 3/14 (21.43) | 4.165 (1.122–15.451) | 0.022 |
Daunorubicin | 28/84 (33.33) | 27/78 (34.62) | 1/6 (16.67) | 2.647 (0.294–23.821) | 0.653 | |
Idarubicin | 90/203 (44.33) | 83/183 (45.35) | 7/20 (35.00) | 1.541 (0.589–4.041) | 0.376 | |
Mitoxantrone | 114/287 (39.72) | 107/264 (40.53) | 7/23 (30.43) | 1.558 (0.620–3.915) | 0.343 | |
Pirarubicin | 21/74 (28.38) | 20/69 (28.99) | 1/5 (20.00) | 1.633 (0.172–15.524) | 1.000 | |
First or second cycle | Aclarubicin | 243/379 (64.12) | 229/349 (65.62) | 14/30 (46.67) | 2.181 (1.030–4.619) | 0.038 |